However, a lower proportion of PD-L1 strongly positive cells was observed in NSCLC patients harboring EGFR mutations than wild-type patients, revealing a negative correlation between EGFR mutation status and PD-L1 expression (P = 0.003; Figure 4A). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.